PeptiDream Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

PeptiDream has been growing earnings at an average annual rate of 33.5%, while the Biotechs industry saw earnings growing at 10.5% annually. Revenues have been growing at an average rate of 39.6% per year. PeptiDream's return on equity is 36.9%, and it has net margins of 39.1%.

Anahtar bilgiler

33.5%

Kazanç büyüme oranı

32.8%

EPS büyüme oranı

Biotechs Sektör Büyümesi31.9%
Gelir büyüme oranı39.6%
Özkaynak getirisi36.9%
Net Marj39.1%
Sonraki Kazanç Güncellemesi13 Nov 2024

Yakın geçmiş performans güncellemeleri

Recent updates

PeptiDream Inc.'s (TSE:4587) Price Is Out Of Tune With Earnings

Oct 31
PeptiDream Inc.'s (TSE:4587) Price Is Out Of Tune With Earnings

Do PeptiDream's (TSE:4587) Earnings Warrant Your Attention?

Oct 15
Do PeptiDream's (TSE:4587) Earnings Warrant Your Attention?

PeptiDream Inc. (TSE:4587) Shares Could Be 37% Below Their Intrinsic Value Estimate

Aug 29
PeptiDream Inc. (TSE:4587) Shares Could Be 37% Below Their Intrinsic Value Estimate

PeptiDream Inc. Just Beat Revenue Estimates By 13%

Aug 12
PeptiDream Inc. Just Beat Revenue Estimates By 13%

PeptiDream Inc. (TSE:4587) Surges 27% Yet Its Low P/S Is No Reason For Excitement

Jun 30
PeptiDream Inc. (TSE:4587) Surges 27% Yet Its Low P/S Is No Reason For Excitement

News Flash: Analysts Just Made A Meaningful Upgrade To Their PeptiDream Inc. (TSE:4587) Forecasts

Jun 02
News Flash: Analysts Just Made A Meaningful Upgrade To Their PeptiDream Inc. (TSE:4587) Forecasts

PeptiDream Inc.'s (TSE:4587) 42% Price Boost Is Out Of Tune With Revenues

Apr 30
PeptiDream Inc.'s (TSE:4587) 42% Price Boost Is Out Of Tune With Revenues

Is PeptiDream Inc. (TSE:4587) Trading At A 46% Discount?

Apr 29
Is PeptiDream Inc. (TSE:4587) Trading At A 46% Discount?

PeptiDream Inc.'s (TSE:4587) 25% Jump Shows Its Popularity With Investors

Mar 03
PeptiDream Inc.'s (TSE:4587) 25% Jump Shows Its Popularity With Investors

Gelir ve Gider Dağılımı

PeptiDream nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

TSE:4587 Gelir, gider ve kazançlar (JPY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 2455,41921,6897,0493,120
31 Mar 2427,9742,4416,8573,137
31 Dec 2328,7123,0356,6733,155
30 Sep 2338,18711,2816,9703,286
30 Jun 2331,2547,9566,8453,257
31 Mar 2331,3968,1356,8333,229
31 Dec 2226,8527,5545,8302,915
30 Sep 2212,811574,9441,888
30 Jun 2211,5111,7053,8621,164
31 Mar 228,3262,3412,759394
31 Dec 219,3663,6062,5900
30 Sep 2115,6077,1102,6930
30 Jun 2111,4494,3292,6230
31 Mar 2112,7435,2262,5270
31 Dec 2011,6774,4482,5380
31 Dec 192,075-9772,5060
30 Jun 197,2172,7701,9860
30 Jun 186,4272,3351,7370
31 Mar 184,6168951,7970
30 Sep 174,2719621,6470
30 Jun 174,8961,8911,0460
31 Mar 173,0647698260
31 Dec 164,4571,6857640
30 Sep 164,7351,8237390
30 Jun 164,3281,5816940
31 Mar 164,6201,9766030
31 Dec 153,1211,2034810
30 Sep 152,7221,0634090
30 Jun 152,4741,0043620
31 Mar 15757463100
31 Dec 14739673070
30 Sep 147861183010
30 Jun 148191493030

Kaliteli Kazançlar: 4587 has a high level of non-cash earnings.

Büyüyen Kar Marjı: 4587's current net profit margins (39.1%) are higher than last year (25.5%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 4587's earnings have grown significantly by 33.5% per year over the past 5 years.

Büyüme Hızlandırma: 4587's earnings growth over the past year (172.6%) exceeds its 5-year average (33.5% per year).

Kazançlar vs. Sektör: 4587 earnings growth over the past year (172.6%) exceeded the Biotechs industry 4%.


Özkaynak Getirisi

Yüksek ROE: 4587's Return on Equity (36.9%) is considered high.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin